Ubiosis Co.,Ltd.

Ubiosis Health develops UBi, an AI-driven healthcare agent and autonomous nursing platform purpose-built for inflammatory bowel disease (IBD) management. UBi bridges gaps between clinic visits through continuous at-home biomarker monitoring (fecal calprotectin, weight, heart-rate variability), real-time EMR data streaming, natural-language patient engagement via mobile app, and automated clinical workflows including prior authorizations and lab ordering. The platform implements STRIDE-II treat-to-target guidelines at scale, enabling early flare detection and proactive intervention before symptoms escalate. Designed for seamless integration into existing gastroenterology practice workflows without requiring new staff or system installations, UBi delivers clinical outcomes (5× increase in sustained remission rates, 81% reduction in adverse events per CALM trial data) while generating new reimbursable revenue through remote patient monitoring and chronic care management CPT codes. The platform has conducted over 1,200+ patient check-ins weekly and is partnered with leading academic medical centers and health systems.